The role of carnitine supplementation during valproic acid therapy.
about
L-Carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cellsValproic acid is associated with cognitive decline in HIV-infected individuals: a clinical observational study.Valproic acid toxicity: overview and management.Hyperammonemic Encephalopathy due to Valproic Acid and Topiramate Interaction.Valproic acid-associated acute liver failure in children: case report and analysis of liver transplantation outcomes in the United States.Placebo-controlled trial of valproic Acid versus risperidone in children 3-7 years of age with bipolar I disorder.Endocrine and metabolic changes in epileptic patients receiving valproic acid.The Effect of Carnitine Supplementation on Hyperammonemia and Carnitine Deficiency Treated with Valproic Acid in a Psychiatric Setting.Valproate Induced Hyperammonemic Delirium.Effects of L-carnitine in patients with hepatic encephalopathy.Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity.Drug metabolite profiling and elucidation of drug-induced hepatotoxicity.Two cases of valproic acid poisoning treated with L-carnitine.Valproic Acid-induced hyperammonemia in the elderly: a review of the literatureCarnitine in the treatment of valproic acid-induced toxicity.Metabolic bioactivation and drug-related adverse effects: current status and future directions from a pharmaceutical research perspective.Hyperammonemia in review: pathophysiology, diagnosis, and treatment.Brain carnitine deficiency causes nonsyndromic autism with an extreme male bias: A hypothesis.L-Carnitine supplementation to reverse hyperammonemia in a patient undergoing chronic valproic acid treatment: A case report.Valproate monotherapy induced-delirium due to hyperammonemia: A report of three adult cases with different types of presentation.Sudden valproate-induced hyperammonemia managed with L-carnitine in a medically healthy bipolar patient: Essential review of the literature and case report.Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report.Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients.Valproic acid induced acute liver injury resulting in hepatic encephalopathy- a case report and literature review
P2860
Q24298663-48C3C761-F431-4BF3-A655-264B975860F7Q24813193-4023438F-3330-4A3C-AB2B-AD3B1EFA421DQ28189745-B24AAACC-C453-448E-A991-DC96A523569CQ33265632-36845FE4-0FCD-407E-9F0C-4385BA5556C4Q33963043-E6DDE933-A730-420C-BD96-4DBE0C0BF261Q34022325-14A71CC3-3018-4862-ADAF-5AA219DAC587Q34785900-F21C8A58-6853-4276-A184-09D0AD977B6DQ35641684-C3548071-4A88-4AE5-B209-447F018D2A47Q36142002-1218E256-4B2B-4EA3-97FD-F427BCAEC157Q36307063-8325DF06-BA6F-4072-8620-B8015214AB93Q36476422-FB81C421-7396-4522-A690-05B8244EE0ACQ36496834-3F583E96-A368-49DA-B3B0-922D27108690Q36548488-6A9B4F09-9C78-47E9-BC3F-FA445EF6ECE8Q36835826-B51ABED5-3FF9-4146-A5CB-1DE04FCC29F2Q37122831-DBFD2BE4-F722-4997-A8CC-5563D6DA7FA7Q37317489-23259287-5DF3-4F53-8857-ADDC2EC22B1CQ37413086-82CF65B2-D3B2-4C10-9190-56B6C11DB535Q37638755-CAC4AB1E-DE36-438F-A6F7-A28755C90AD2Q37856806-F7002634-7ECA-4C1D-95E4-47BC3ABDA012Q39432351-5E5296F1-56E5-4000-968A-FA972D01EF0CQ41864413-5B05FCD8-C265-4CE0-9DAC-98F690325856Q41886184-60E0747B-A204-4A40-8298-31F8A10F86C9Q42128344-13A57B53-3EC5-458D-9C81-2E789B8E4EC9Q44541526-BD5A3945-62DE-4527-A1A1-47E386E25C91Q46780453-0347627B-4029-4435-9D26-71447859CEBAQ57814899-C095682C-DDE7-42EC-9726-49BD56DD2BCB
P2860
The role of carnitine supplementation during valproic acid therapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The role of carnitine supplementation during valproic acid therapy.
@ast
The role of carnitine supplementation during valproic acid therapy.
@en
type
label
The role of carnitine supplementation during valproic acid therapy.
@ast
The role of carnitine supplementation during valproic acid therapy.
@en
prefLabel
The role of carnitine supplementation during valproic acid therapy.
@ast
The role of carnitine supplementation during valproic acid therapy.
@en
P2860
P356
P1476
The role of carnitine supplementation during valproic acid therapy.
@en
P2093
G M El-Chaar
J Y Raskind
P2860
P304
P356
10.1345/APH.19242
P407
P577
2000-05-01T00:00:00Z